BRAVO 3: Choice of vascular closure device in TAVR matters

LAS VEGAS — In a comparison of two vascular closure devices used in transfemoral transcatheter aortic valve replacement procedures, the Perclose ProGlide device was associated with lower rates of vascular complications and acute kidney injury compared with the Prostar XL device, according to new data from the BRAVO 3 trial.
In a post hoc analysis of BRAVO 3 presented at the Society for

Related Keywords

Perclose Proglide ,Erik Swain ,Icahn School Of Medicine At Mount Sinai ,Society For Cardiovascular Angiography ,Academic Research Consortium ,Cardiovascular Angiography ,Interventions Scientific Sessions ,Icahn School ,Mount Sinai ,Abbott Vascular ,Cardiology Today ,Bleeding Academic Research Consortium ,